Chronic angiotensin II infusion drives extensive aldosterone-independent epithelial Na+ channel activation.
Chronic angiotensin II infusion drives extensive aldosterone-independent epithelial Na+ channel activation.
复制标题
DOI:
10.1161/hypertensionaha.113.01797
复制
发表时间:
2013-12
期刊:
影响因子:
--
通讯作者:
Pochynyuk O
中科院分区:
文献类型:
--
作者:
Mamenko M;Zaika O;Prieto MC;Jensen VB;Doris PA;Navar LG;Pochynyuk O
The inability of mineralocorticoid receptor (MR) blockade to reduce hypertension associated with high Angiotensin (Ang) II suggests direct actions of Ang II to regulate tubular sodium reabsorption via the epithelial Na+ channel (ENaC) in the aldosterone-sensitive distal nephron (ASDN). We used freshly isolated ASDN from mice to delineate the synergism and primacy between aldosterone and Ang II in controlling functional ENaC activity. Inhibition of MR specifically prevented the increased number of functionally active ENaC but not ENaC open probability elicited by a low sodium diet. In contrast, we found no functional role of glucocorticoid receptors (GR) in the regulation of ENaC activity by dietary salt intake. Simultaneous inhibition of MR and Ang II type 1 receptors (AT1R) ameliorated the enhanced ENaC activity caused by low dietary salt intake and produced significantly greater natriuresis than either inhibitor alone. Chronic systemic Ang II infusion induced more than two times greater increase in ENaC activity than observed during dietary sodium restriction. Importantly, ENaC activity remained greatly above control levels during maximal MR inhibition. We conclude that during variations in dietary salt intake both aldosterone and Ang II contribute complementarily to the regulation of ENaC activity in the ASDN. In contrast, in the setting of Ang II-dependent hypertension, ENaC activity is up-regulated well above the physiological range and is not effectively suppressed by inhibition of the aldosterone-MR axis. This provides a mechanistic explanation for the resistance to MR inhibition that occurs in hypertensive subjects having elevated intrarenal Ang II levels.